Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2
dc.contributor.author | Foley, A. Reghan | |
dc.contributor.author | Menezes, Manoj P. | |
dc.contributor.author | Pandraud, Amelie | |
dc.contributor.author | Gonzalez, Michael A. | |
dc.contributor.author | Al-Odaib, Ahmad | |
dc.contributor.author | Abrams, Alexander J. | |
dc.contributor.author | Sugano, Kumiko | |
dc.contributor.author | Yonezawa, Atsushi | |
dc.contributor.author | Manzur, Adnan Y. | |
dc.contributor.author | Burns, Joshua | |
dc.contributor.author | Hughes, Imelda | |
dc.contributor.author | McCullagh, B. Gary | |
dc.contributor.author | Jungbluth, Heinz | |
dc.contributor.author | Lim, Ming J. | |
dc.contributor.author | Lin, Jean-Pierre | |
dc.contributor.author | Megarbane, Andre | |
dc.contributor.author | Urtizberea, J. Andoni | |
dc.contributor.author | Shah, Ayaz H. | |
dc.contributor.author | Antony, Jayne | |
dc.contributor.author | Webster, Richard | |
dc.contributor.author | Broomfield, Alexander | |
dc.contributor.author | Ng, Joanne | |
dc.contributor.author | Mathew, Ann A. | |
dc.contributor.author | O'Byrne, James J. | |
dc.contributor.author | Forman, Eva | |
dc.contributor.author | Scoto, Mariacristina | |
dc.contributor.author | Prasad, Manish | |
dc.contributor.author | O'Brien, Katherine | |
dc.contributor.author | Olpin, Simon | |
dc.contributor.author | Oppenheim, Marcus | |
dc.contributor.author | Hargreaves, Iain | |
dc.contributor.author | Land, John M. | |
dc.contributor.author | Wang, Min X. | |
dc.contributor.author | Carpenter, Kevin | |
dc.contributor.author | Horvath, Rita | |
dc.contributor.author | Straub, Volker | |
dc.contributor.author | Lek, Monkol | |
dc.contributor.author | Gold, Wendy | |
dc.contributor.author | Farrell, Michael O. | |
dc.contributor.author | Brandner, Sebastian | |
dc.contributor.author | Phadke, Rahul | |
dc.contributor.author | Matsubara, Kazuo | |
dc.contributor.author | McGarvey, Michael L. | |
dc.contributor.author | Scherer, Steven S. | |
dc.contributor.author | Baxter, Peter S. | |
dc.contributor.author | King, Mary D. | |
dc.contributor.author | Clayton, Peter | |
dc.contributor.author | Rahman, Shamima | |
dc.contributor.author | Reilly, Mary M. | |
dc.contributor.author | Ouvrier, Robert A. | |
dc.contributor.author | Christodoulou, John | |
dc.contributor.author | Zuechner, Stephan | |
dc.contributor.author | Muntoni, Francesco | |
dc.contributor.author | Houlden, Henry | |
dc.date.accessioned | 2014-08-28T15:27:01Z | |
dc.date.available | 2014-08-28T15:27:01Z | |
dc.date.issued | 2014-01 | |
dc.identifier | 40057623 | |
dc.identifier | b9040a09-aebe-4ad4-a27a-2ab3f7c70fca | |
dc.identifier | 000330434000008 | |
dc.identifier | 84892712366 | |
dc.identifier.citation | Foley , A R , Menezes , M P , Pandraud , A , Gonzalez , M A , Al-Odaib , A , Abrams , A J , Sugano , K , Yonezawa , A , Manzur , A Y , Burns , J , Hughes , I , McCullagh , B G , Jungbluth , H , Lim , M J , Lin , J-P , Megarbane , A , Urtizberea , J A , Shah , A H , Antony , J , Webster , R , Broomfield , A , Ng , J , Mathew , A A , O'Byrne , J J , Forman , E , Scoto , M , Prasad , M , O'Brien , K , Olpin , S , Oppenheim , M , Hargreaves , I , Land , J M , Wang , M X , Carpenter , K , Horvath , R , Straub , V , Lek , M , Gold , W , Farrell , M O , Brandner , S , Phadke , R , Matsubara , K , McGarvey , M L , Scherer , S S , Baxter , P S , King , M D , Clayton , P , Rahman , S , Reilly , M M , Ouvrier , R A , Christodoulou , J , Zuechner , S , Muntoni , F & Houlden , H 2014 , ' Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2 ' , Brain , vol. 137 , no. 1 , pp. 44-56 . https://doi.org/10.1093/brain/awt315 | en |
dc.identifier.issn | 0006-8950 | |
dc.identifier.uri | http://hdl.handle.net/2164/3396 | |
dc.format.extent | 13 | |
dc.format.extent | 1185321 | |
dc.language.iso | eng | |
dc.relation.ispartof | Brain | en |
dc.subject | childhood neuronopathy | en |
dc.subject | Brown-Vialetto-Van Laere syndrome | en |
dc.subject | riboflavin therapy | en |
dc.subject | RFVT2 | en |
dc.subject | SLC52A2 | en |
dc.subject | Vialetto-Van-Laere | en |
dc.subject | Fazio-Londe-Disease | en |
dc.subject | autosomal recessive inheritance | en |
dc.subject | progressive bulbar paralysis | en |
dc.subject | pontobulbar palsy | en |
dc.subject | Vanlaere syndrome | en |
dc.subject | deafness | en |
dc.subject | overlap | en |
dc.subject | family | en |
dc.subject | brain | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2 | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.University of Aberdeen | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1093/brain/awt315 |